Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Ausperbio Therapeutics Inc.

Clinical trials sponsored by Ausperbio Therapeutics Inc., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New shot aims to tame hepatitis b without daily pills Results expected May 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1

New injection aims to tame chronic hepatitis b

Disease control Not yet recruiting

This early-phase study tests a new injectable drug called AHB-171 in 144 adults with chronic hepatitis B. The main goals are to check the drug's safety and how the body processes it. Some participants will also take standard oral antivirals. The study is not yet recruiting.

Phase 1 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC